Overall, the results by Lee et al. [53] and Hua et al. [56] support the concept that in murine NOTCH1-mutated T-ALL models, mTORC2 is a critical regulator of leukemia progression that impacts a variety of genes targeted by both NFκB and FoxO3a. Here, NFKB1 is linked to acute lymphoblastic leukemia.